Case Histories of Significant Medical Advances: Cephalosporins

19 Pages Posted: 24 Aug 2020

See all articles by Amar Bhide

Amar Bhide

Tufts University - The Fletcher School of Law and Diplomacy

Srikant Datar

Harvard University - Accounting & Control Unit

Katherine Stebbins

Harvard University - Business School (HBS)

Date Written: August 21, 2020

Abstract

Our case history describes the development of three generations of cephalosporins – antibiotics that have significantly reduced hospital infections. Specifically, we chronicle how: 1) Early (pre-cephalosporin) antibiotics were developed in the first half of the 20th century. 2) Drug companies developed first-generation cephalosporins in the 1960s using foundational discoveries made by researchers in Italy and the UK in the 1940s and 1950s. 3) Continued modifications of cephalosporin molecules resulted in second and third generation of the drugs in the 1970s and 1980s.

Suggested Citation

Bhide, Amar and Datar, Srikant and Stebbins, Katherine, Case Histories of Significant Medical Advances: Cephalosporins (August 21, 2020). Harvard Business School General Management Unit Working Paper No. 20-133, Harvard Business School Accounting & Management Unit Working Paper No. 20-133, Available at SSRN: https://ssrn.com/abstract=3679640 or http://dx.doi.org/10.2139/ssrn.3679640

Amar Bhide

Tufts University - The Fletcher School of Law and Diplomacy ( email )

Cabot 505
160 Packard Avenue
Medford, MA 02155
United States
617-229-5050 (Phone)

HOME PAGE: http://www.bhide.net

Srikant Datar (Contact Author)

Harvard University - Accounting & Control Unit ( email )

Soldiers Field
Boston, MA 02163
United States
617-495-6543 (Phone)
617-496-7363 (Fax)

Katherine Stebbins

Harvard University - Business School (HBS) ( email )

Soldiers Field Road
Morgan 270C
Boston, MA 02163
United States

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
1
Abstract Views
135
PlumX Metrics